JSR Life Sciences 媒体报道

筛选条件：重置

JSR launches services firm for biosimilar development

Selexis, Pandion Enter Antibody Service Agreement

Selexis, Tallac to advance novel immunotherapies

Receive JSR Life Sciences news by email.

Email frequency *

For which language do you want to receive updates? *

Error message

I agree that JSR Life Sciences stores my data in order to send news updates *
Your information is only used to send you news and will never be shared with third parties. Your personal data will be processed in accordance with JSR Life Sciences's 隐私条款.

If you are a human, ignore this field

Thank you for subscribing–we're almost there. We just need to confirm your email address so we know we're sending news to the right person.

The confirmation email will arrive in your inbox shortly.

Subscribe with RSS